Current subjects of faculty research in Wharton’s Health Care Systems Department include research into alternatives to managed care insurance; exploring whether tax-advantaged employer-paid health insurance is sufficient and equitable; and options for developing a comprehensive national health policy for Medicare. The Leonard Davis Institute of Health Economics (LDI) was established in 1967 in response to growing national need for high quality research and education to inform policies critical to the financing and management of the nation’s increasingly costly and complex health care system. It is a cooperative venture among Penn’s business and health professions schools (Wharton, Medicine, Nursing, and Dental Medicine). LDI’s Health Policy Program translates Penn’s wide-ranging activities in health policy research and education into a form useful to private sector decision-makers through such activities as conferences, seminars, workshops, and other interdisciplinary events. The Program provides opportunities for dialogue among health services researchers, students, policy makers and industry leaders. As a research institute LDI does not confer degrees. Its core mission is to advance interdisciplinary health services education in the management, clinical, social, and behavioral sciences.
LAW & BIOTECHNOLOGY Ask the next person you run into to define the term “biotechnology.” You’ll most likely find a person struggling to find the meaning by parsing the word. At best, you’ll likely hear a reference to Frankenstein’s monster. Merely a
year after the course “Biotechnology and the Law” was introduced at Penn
Law School, there is speculation by analysts that his decision this summer
concerning the future of stem cell research may be the issue that defines
George W. Bush’s presidency. The analysis of how law impacts scientific
discovery, and vice versa, is at the core of the Law School’s ambitions
in this area. |
||||
| Previous Page | Next Page | |||
